title: T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro.
authors.affiliation: Department of Urologic Surgery, Vanderbilt-Ingram Cancer Center and Vanderbilt University Medical Center, Nashville, Tennessee, USA.
authors.forename: Peter E
authors.initials: PE
authors.lastname: Clark
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D059248:Chemoradiotherapy; D015653:Cystectomy / Q000009:adverse effects; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*
chemical_list: D001500:BCG Vaccine